Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116123 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mi-Ri Kwon und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul 05505, Re…. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Triple Negative Breast Neoplasms, Cell Movement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, NCIRD CDC HHS, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) accounts for approximately 15–20% of all breast cancer types, indicating a poor survival prognosis with a more aggressive biology of metastasis to the lung and a short response duration to available therapies. Ibulocydine (IB) is a novel (cyclin-dependent kinase) CDK7/9 inhibitor prodrug displaying potent anti-cancer effects against various cancer cell types. We performed in vitro and in vivo experiments to determine whether IB inhibits metastasis and eventually overcomes the poor drug response in TNBC. The result showed that IB inhibited the growth of TNBC cells by inducing caspase-mediated apoptosis and blocking metastasis by reducing MMP-9 expression in vitro. Concurrently, in vivo experiments using the metastasis model showed that IB inhibited metastasis of MDA-MB-231-Luc cells to the lung. Collectively, these results demonstrate that IB inhibited the growth of TNBC cells and blocked metastasis by regulating MMP-9 expression, suggesting a novel therapeutic agent for metastatic TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
- Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
- Asan Preclinical Evaluation Center for Cancer Therapeutix, Asan Medical Center, Seoul 05505, Republic of Korea.
- Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Life Science, Chung-Ang University, Seoul 06974, Republic of Korea.
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
ORCID-Profile: Yun-Yong Park, Myoung-Hee Kang, Byeong-Moon Kim, Seok-Soon Park
Förderung
- National Research Foundation of Korea
- NCIRD CDC HHS
- Korea Health Industry Development Institute
- Asan Medical Center
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Bio&Medical Technology Development Program of the National Research Foundation
- Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
Zitieren
APA
Kwon, M. R., Park, J. S., Ko, E. J., Park, J., Ju, E. J., Shin, S. H., Son, G. W., Lee, H. W., Park, Y. Y., Kang, M. H., Kim, Y. J., Kim, B. M., Lee, H. J., Kim, T. W., Kim, C. J., Song, S. Y., Park, S. S., & Jeong, S. Y. (2024). Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116123
Vancouver
Kwon MR, Park JS, Ko EJ, Park J, Ju EJ, Shin SH, et al. Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116123
BibTeX
@article{Kwon2024,
author = {Kwon, Mi-Ri and Park, Ji-Soo and Ko, Eun-Jung and Park, Jin and Ju, Eun-Jin and Shin, Seol-Hwa and Son, Ga-Won and Lee, Hye-Won and Park, Yun-Yong and Kang, Myoung-Hee and Kim, Yeon-Joo and Kim, Byeong-Moon and Lee, Hee-Jin and Kim, Tae-Won and Kim, Chong-Jai and Song, Si-Yeol and Park, Seok-Soon and Jeong, Seong-Yun},
title = {Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116123}
}
EUVIMED